Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Oncology Institute (TOI) Debt to Equity (2020 - 2025)

Oncology Institute (TOI) has disclosed Debt to Equity for 6 consecutive years, with -$6.21 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Debt to Equity fell 205.0% year-over-year to -$6.21, compared with a TTM value of -$6.21 through Sep 2025, down 205.0%, and an annual FY2024 reading of $25.95, up 1604.26% over the prior year.
  • Debt to Equity was -$6.21 for Q3 2025 at Oncology Institute, up from -$8.35 in the prior quarter.
  • Across five years, Debt to Equity topped out at $25.95 in Q4 2024 and bottomed at -$8.35 in Q2 2025.
  • Average Debt to Equity over 5 years is $3.06, with a median of $1.09 recorded in 2023.
  • The sharpest move saw Debt to Equity surged 37153.86% in 2022, then crashed 371.11% in 2025.
  • Year by year, Debt to Equity stood at $0.0 in 2021, then soared by 37153.86% to $0.65 in 2022, then skyrocketed by 132.63% to $1.52 in 2023, then surged by 1604.26% to $25.95 in 2024, then plummeted by 123.92% to -$6.21 in 2025.
  • Business Quant data shows Debt to Equity for TOI at -$6.21 in Q3 2025, -$8.35 in Q2 2025, and $14.58 in Q1 2025.